Why US-funded vaccine trial plan for babies in Guinea-Bissau caused outrage
Summary
Danish researchers planned a vaccine study in Guinea-Bissau funded by the U.S. This study aimed to test hepatitis B vaccines given at birth or six weeks later on 14,000 babies. However, public outrage stopped the trial due to ethical concerns.Key Facts
- Danish scientists wanted to study hepatitis B vaccination timing in Guinea-Bissau.
- The plan involved giving half the babies the vaccine at birth and the other half six weeks later.
- The study faced backlash from international health experts over ethical concerns.
- The Guinea-Bissau government halted the study pending further review.
- Babies are most at risk for hepatitis B infection, which can cause severe health issues.
- Guinea-Bissau has a high hepatitis B infection rate, affecting about 20% of the population.
- WHO guidelines recommend hepatitis B vaccination at birth followed by booster shots.
- Ethical concerns arose because part of the study group would have delayed vaccination.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.